VEGFA and neoplasm: Studies 34-37 have found that antiangiogenic drugs can block immunosuppressive signals by reversing vascular endothelial growth factor, promoting lymphocyte infiltration and migration and other pathways, and can also enhance immune efficacy by normalizing tumor blood vessels.